STAT3 and central nervous system cancer: Furthermore, GSK126, a selective small molecule Ezh2 inhibitor that is structurally related to GSK503 [13], has been shown to decrease levels of phosphorylated STAT3 (pSTAT3) in glioma cells that resemble stem cells [6].